Mustang Bio, Inc. (MBIO)

Mustang Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	17	12	42	155	247	165
Market Cap Growth	-73.26%	-70.64%	-72.68%	-37.19%	49.20%	106.47%
Enterprise Value	18	8	-3	47	150	119
PE Ratio	-	-0.24	-0.55	-2.34	-4.11	-3.57
PB Ratio	-2.19	101.16	0.92	1.38	2.51	3.20
P/FCF Ratio	-0.35	-0.29	-0.63	-2.69	-6.29	-4.61
P/OCF Ratio	-0.29	-0.25	-0.65	-2.89	-6.62	-4.93
EV/EBITDA Ratio	-0.33	-0.18	0.04	-0.73	-2.77	-2.74
EV/EBIT Ratio	-0.31	-0.17	0.04	-0.70	-2.68	-2.66
EV/FCF Ratio	-0.37	-0.18	0.04	-0.81	-3.83	-3.30
Debt / Equity Ratio	-0.48	20.31	0.68	0.02	0.02	0.30
Debt / EBITDA Ratio	-0.07	-0.06	-0.44	-0.03	-0.04	-0.36
Debt / FCF Ratio	-0.08	-0.06	-0.46	-0.04	-0.06	-0.43
Quick Ratio	0.48	0.71	5.09	10.23	10.39	8.03
Current Ratio	0.53	0.74	5.22	10.33	10.46	8.12
Interest Coverage	-12.67	-11.56	-22.08	-4423.67	-14.32	-25.25
Return on Equity (ROE)	-1243.20%	-433.10%	-107.00%	-52.80%	-82.30%	-86.70%
Return on Assets (ROA)	-195.60%	-146.40%	-67.40%	-48.70%	-66.40%	-61.80%
Return on Capital (ROIC)	1499.21%	-1879.44%	-98.07%	-58.31%	-56.43%	-68.30%
Earnings Yield	-235.83%	-414.70%	-182.95%	-42.79%	-24.30%	-28.03%
FCF Yield	-182.63%	-349.92%	-159.66%	-37.17%	-15.89%	-21.71%
Buyback Yield / Dilution	-39.04%	-11.97%	-31.16%	-67.12%	-45.83%	-33.81%
Total Shareholder Return	-39.04%	-11.97%	-31.16%	-67.12%	-45.83%	-33.81%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).